Stop Funding Genital Mutilation Act
- Bill Number
- S. 2008
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Status
- Introduced
- Latest Action
- 2025-06-10: Read twice and referred to the Committee on Finance.
- Last Updated
- 2025-06-19T03:38:15Z
AI-Generated Summary
Purpose
The legislation, titled the "Stop Funding Genital Mutilation Act," aims to prevent federal funding from Medicaid (a joint federal-state health insurance program for low-income individuals) and CHIP (Children's Health Insurance Program, which covers children in low-income families) for procedures intended to change a person's body to align with a gender identity different from their biological sex. It seeks to limit taxpayer money for what the bill describes as "specified gender transition procedures."
Key Provisions
- Prohibition on Funding: Federal payments under Medicaid and CHIP are barred for "specified gender transition procedures" provided to enrollees. These include surgeries (e.g., castration, hysterectomy, mastectomy, phalloplasty, vaginoplasty), implants (e.g., breast or testicular prostheses), and medications (e.g., puberty blockers like GnRH analogues, or high-dose hormones like testosterone or estrogen).
- Definition of Procedures: A "specified gender transition procedure" is any medical intervention that intentionally alters the body's development, functions, or appearance to mismatch the individual's biological sex (defined as male or female based on reproductive systems that produce sperm or eggs, respectively, accounting for natural anomalies).
- Exceptions: The ban does not apply to:
- Puberty-blocking drugs used to treat precocious puberty (early onset of puberty) with parental consent.
- Medically necessary treatments for disorders of sex development (e.g., genetic conditions like 46,XX with virilization), abnormalities in sex chromosomes or hormones confirmed by testing, infections/injuries from prior procedures, life-threatening conditions (excluding mental health relief), or reversal surgeries to restore the body to match biological sex.
- Implementation: States cannot receive federal matching funds for these procedures, with parental or guardian consent required for exceptions in minors.
Significant Changes to Existing Law
- Amends Section 1903(i) of the Social Security Act to add a new exclusion (paragraph 28) for gender transition procedures in Medicaid, similar to existing bans on funding for non-medical abortions or certain experimental treatments.
- Updates CHIP provisions to cross-reference this new Medicaid exclusion, ensuring consistency across both programs.
- Introduces a detailed federal definition of biological "sex" (male/female) and specifies what constitutes prohibited procedures, which previously lacked such explicit restrictions in these programs. This shifts from state discretion to a uniform federal standard.
Potential Impacts
- On Government Agencies: The Centers for Medicare & Medicaid Services (CMS) and state Medicaid agencies will need to update eligibility rules, billing systems, and oversight to enforce the ban, potentially increasing administrative costs and compliance audits.
- On Citizens: Low-income individuals, particularly transgender or gender-nonconforming people, may lose access to federally subsidized gender-affirming care, forcing reliance on private insurance, out-of-pocket payments, or state-only funds (if available). Children in CHIP could face barriers to certain treatments, though exceptions protect specific medical needs.
- On International Relations: Minimal direct impact, but it could influence U.S. stance in global health discussions on LGBTQ+ rights or human rights, potentially drawing criticism from countries or organizations advocating for gender-affirming care.
Main Stakeholders Affected
- Transgender and Gender-Nonconforming Individuals: Primary group impacted, as they may face reduced access to care under public programs.
- State Governments and Medicaid/CHIP Administrators: Responsible for implementing changes, which could strain budgets if states choose to fund prohibited procedures with non-federal dollars.
- Healthcare Providers: Doctors, surgeons, and clinics offering these services risk losing reimbursements, potentially limiting services in Medicaid-participating facilities.
- Federal Government (Congress and CMS): Bears the cost savings from reduced funding but faces enforcement responsibilities.
- Parents and Guardians of Minors: Involved in consenting to exceptions for conditions like precocious puberty or disorders of sex development.
- Advocacy Groups: Organizations for LGBTQ+ rights, medical associations (e.g., American Medical Association), and conservative policy groups will likely engage in debates over the bill's effects.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: The bill's strict definition of "sex" based on biology could conflict with evolving court interpretations of sex discrimination under Title VII or the Equal Protection Clause of the 14th Amendment, potentially leading to lawsuits claiming it denies equal access to healthcare. Exceptions for medical necessities might mitigate some challenges but could invite disputes over what qualifies as "medically necessary."
- Constitutional Implications: Raises questions about federal overreach into state-run programs (Medicaid is jointly funded) and individual rights to bodily autonomy or privacy under the Due Process Clause. It does not directly address minors' rights but could indirectly affect them via parental consent requirements.
- Political Implications: Highly partisan, reflecting debates on gender identity, healthcare funding, and cultural issues; passage could energize social conservative bases while alienating progressive groups, influencing future elections or related legislation on transgender rights. If enacted, it sets a precedent for federal limits on state health programs without violating the 10th Amendment (states' rights), as it only conditions federal funds.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2025-06-10: Read twice and referred to the Committee on Finance.
- 2025-06-10: Introduced in Senate
Bill Versions
- Stop Funding Genital Mutilation Act — issued 2025-06-10 — PDF (7 pages)